Skip to main content
Top
Published in: Journal of Clinical Immunology 1/2010

Open Access 01-01-2010

Mycobacterial ESAT-6 and katG are Recognized by Sarcoidosis CD4+ T Cells When Presented by the American Sarcoidosis Susceptibility Allele, DRB1*1101

Authors: Kyra Oswald-Richter, Hiroe Sato, Rana Hajizadeh, Bryan E. Shepherd, John Sidney, Alessandro Sette, Lee S. Newman, Wonder Puryear Drake

Published in: Journal of Clinical Immunology | Issue 1/2010

Login to get access

Abstract

Introduction

Genetic associations of American sarcoidosis susceptibility implicate MHC class II allele, DRB1*1101. We previously reported immune recognition of Mycobacterium peptides from peripheral cells of 26 sarcoidosis subjects, 24 PPD− healthy volunteers, and eight with latent tuberculosis infection.

Materials and Methods

In order to further link these genetic and immunologic pillars of sarcoidosis pathogenesis, we performed flow cytometry on these same subjects to identify the cells responsible for immune responses to ESAT-6 and katG peptides, followed by HLA typing to determine allelic associations with recognition.

Discussion and Conclusion

Sarcoidosis CD4+ T cells were primarily responsible for the systemic responses. Recognition was inhibited by monoclonal antibody against HLA-DR and HLA-DQ, but not HLA-DP. Immune recognition of ESAT-6 peptide NNALQNLARTISEAG was associated with possession of DRB1*1101. ESAT-6 and katG presented by antigen-presenting cells expressing DRB1*1101-induced Th-1 responses from sarcoidosis T cells, thus providing a mechanistic insight for the association of HLA DRB1*1101 with sarcoidosis, and sarcoidosis T cell interaction with microbial antigens.
Literature
1.
go back to reference Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in subjects with pulmonary Sarcoidosis. J Clin Invest. 1985;75:1488–95.CrossRefPubMed Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in subjects with pulmonary Sarcoidosis. J Clin Invest. 1985;75:1488–95.CrossRefPubMed
2.
go back to reference Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952–60.PubMed Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952–60.PubMed
3.
go back to reference Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O’Neill SJ, et al. Role of IL-18 in CD4+ T lymphocyte activation in Sarcoidosis. J Immunol. 2000;165:4718–24.PubMed Greene CM, Meachery G, Taggart CC, Rooney CP, Coakley R, O’Neill SJ, et al. Role of IL-18 in CD4+ T lymphocyte activation in Sarcoidosis. J Immunol. 2000;165:4718–24.PubMed
4.
go back to reference Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of IL-2 by lung T lymphocytes in active pulmonary sarcoidosis in primarily from the Leu3+DR+T cell subset. J Clin Invest. 1986;77:1962–70.CrossRefPubMed Saltini C, Spurzem JR, Lee JJ, Pinkston P, Crystal RG. Spontaneous release of IL-2 by lung T lymphocytes in active pulmonary sarcoidosis in primarily from the Leu3+DR+T cell subset. J Clin Invest. 1986;77:1962–70.CrossRefPubMed
5.
6.
go back to reference Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens. 1983;22:200–203.PubMedCrossRef Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens. 1983;22:200–203.PubMedCrossRef
7.
go back to reference Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax. 1984;39:19–22.CrossRefPubMed Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax. 1984;39:19–22.CrossRefPubMed
8.
go back to reference Grunewald J, Eklund A. Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179(4):307–12.CrossRefPubMed Grunewald J, Eklund A. Löfgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179(4):307–12.CrossRefPubMed
9.
go back to reference Spagnolo P, Sato H, Grunewald J, Brynedal B, Hillert J, Mana J, et al. A common haplotype of the C–C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren’s syndrome. J Intern Med. 2008;264:433–41.CrossRefPubMed Spagnolo P, Sato H, Grunewald J, Brynedal B, Hillert J, Mana J, et al. A common haplotype of the C–C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Lofgren’s syndrome. J Intern Med. 2008;264:433–41.CrossRefPubMed
10.
go back to reference Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720–35.CrossRefPubMed Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720–35.CrossRefPubMed
11.
go back to reference Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(3):180–9.PubMed Dubaniewicz A, Dubaniewicz-Wybieralska M, Moszkowska G, Sternau A, Dubaniewicz A. Comparative analysis of DR and DQ alleles occurrence in sarcoidosis and tuberculosis in the same ethnic group: preliminary study. Sarcoidosis Vasc Diffuse Lung Dis. 2006;23(3):180–9.PubMed
12.
go back to reference Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic Sarcoidosis. J Exp Med. 2005;201:755–67.CrossRefPubMed Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic Sarcoidosis. J Exp Med. 2005;201:755–67.CrossRefPubMed
13.
go back to reference Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007;75(1):527–30.CrossRefPubMed Drake WP, Dhason MS, Nadaf M, Shepherd BE, Vadivelu S, Hajizadeh R, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007;75(1):527–30.CrossRefPubMed
14.
go back to reference Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Myśliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology. 2007;12(3):346–54.CrossRefPubMed Dubaniewicz A, Trzonkowski P, Dubaniewicz-Wybieralska M, Dubaniewicz A, Singh M, Myśliwski A. Mycobacterial heat shock protein-induced blood T lymphocytes subsets and cytokine pattern: comparison of sarcoidosis with tuberculosis and healthy controls. Respirology. 2007;12(3):346–54.CrossRefPubMed
15.
go back to reference Satoe H, Grutters JC, Pantelidis P, Mizzon N, Ahmad T, van Houte A-J, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with Sarcoidosis. Am J Respir Cell Mol Biol. 2002;27:406–12. Satoe H, Grutters JC, Pantelidis P, Mizzon N, Ahmad T, van Houte A-J, et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with Sarcoidosis. Am J Respir Cell Mol Biol. 2002;27:406–12.
16.
go back to reference Iannuzzi MC, Maliaric MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance in HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167:1225–31.CrossRefPubMed Iannuzzi MC, Maliaric MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance in HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167:1225–31.CrossRefPubMed
17.
go back to reference Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis. 2002;8(11):1334–41.PubMed Drake WP, Pei Z, Pride DT, Collins RD, Cover TL, Blaser MJ. Molecular analysis of sarcoidosis tissues for mycobacterium species DNA. Emerg Infect Dis. 2002;8(11):1334–41.PubMed
18.
go back to reference Kaufmann DE, Bailey PM, Sidney J, Wagner B, Norris PJ, Johnston MN, et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004;78(9):4463–77.CrossRefPubMed Kaufmann DE, Bailey PM, Sidney J, Wagner B, Norris PJ, Johnston MN, et al. Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol. 2004;78(9):4463–77.CrossRefPubMed
19.
go back to reference Sidney J, Southwood S, Oseroff C, del Guercio MF, Sette A, Grey HM. Measurement of MHC/peptide interactions by gel filtration. Curr Protoc Immunol. 2001;18:3. Sidney J, Southwood S, Oseroff C, del Guercio MF, Sette A, Grey HM. Measurement of MHC/peptide interactions by gel filtration. Curr Protoc Immunol. 2001;18:3.
20.
go back to reference Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K, et al. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000;192:1819–32.CrossRefPubMed Goulder PJ, Tang Y, Brander C, Betts MR, Altfeld M, Annamalai K, et al. Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med. 2000;192:1819–32.CrossRefPubMed
21.
go back to reference Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, et al. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol. 2004;173(3):1966–77.PubMed Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, et al. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol. 2004;173(3):1966–77.PubMed
22.
go back to reference Mustafa AS, Shaban FA, Al-Attiyah R, Abal AT, El-Shamy AM, Andersen P, et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol. 2003;57(2):125–34.CrossRefPubMed Mustafa AS, Shaban FA, Al-Attiyah R, Abal AT, El-Shamy AM, Andersen P, et al. Human Th1 cell lines recognize the Mycobacterium tuberculosis ESAT-6 antigen and its peptides in association with frequently expressed HLA class II molecules. Scand J Immunol. 2003;57(2):125–34.CrossRefPubMed
23.
go back to reference Dubaniewicz A, Kampfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in Sarcoidosis and tuberculosis. Tuberculosis. 2006;6(1):60–7. Dubaniewicz A, Kampfer S, Singh M. Serum anti-mycobacterial heat shock proteins antibodies in Sarcoidosis and tuberculosis. Tuberculosis. 2006;6(1):60–7.
24.
go back to reference Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006;67(8):643–54.CrossRefPubMed Lombard Z, Dalton DL, Venter PA, Williams RC, Bornman L. Association of HLA-DR, -DQ, and vitamin D receptor alleles and haplotypes with tuberculosis in the Venda of South Africa. Hum Immunol. 2006;67(8):643–54.CrossRefPubMed
25.
go back to reference Oftung F, Shinnick TM, Mustafa AS, Lundin KEA, Godal T, et al. Heterogeneity among T-cell clones recognizing an HLA-DR4, Dw4-restricted epitope from the 18 kDa antigen of Mycobacterium leprae defined synthetic peptides. J Immunol. 1990;144:1478.PubMed Oftung F, Shinnick TM, Mustafa AS, Lundin KEA, Godal T, et al. Heterogeneity among T-cell clones recognizing an HLA-DR4, Dw4-restricted epitope from the 18 kDa antigen of Mycobacterium leprae defined synthetic peptides. J Immunol. 1990;144:1478.PubMed
26.
go back to reference Geluk A, Ottenhoff TH. HLA and leprosy in the pre and postgenomic eras. Hum Immunol. 2006;67(6):439–45.CrossRefPubMed Geluk A, Ottenhoff TH. HLA and leprosy in the pre and postgenomic eras. Hum Immunol. 2006;67(6):439–45.CrossRefPubMed
27.
go back to reference Borrás SG, Cotorruelo C, Racca L, Recarte M, Garcías C, Biondi C, et al. Association of leprosy with HLA-DRB1 in an Argentinean population. Ann Clin Biochem. 2008;45(Pt 1):96–8.CrossRefPubMed Borrás SG, Cotorruelo C, Racca L, Recarte M, Garcías C, Biondi C, et al. Association of leprosy with HLA-DRB1 in an Argentinean population. Ann Clin Biochem. 2008;45(Pt 1):96–8.CrossRefPubMed
28.
go back to reference Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest. 1993;91(2):616–28.CrossRefPubMed Valli A, Sette A, Kappos L, Oseroff C, Sidney J, Miescher G, et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest. 1993;91(2):616–28.CrossRefPubMed
Metadata
Title
Mycobacterial ESAT-6 and katG are Recognized by Sarcoidosis CD4+ T Cells When Presented by the American Sarcoidosis Susceptibility Allele, DRB1*1101
Authors
Kyra Oswald-Richter
Hiroe Sato
Rana Hajizadeh
Bryan E. Shepherd
John Sidney
Alessandro Sette
Lee S. Newman
Wonder Puryear Drake
Publication date
01-01-2010
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 1/2010
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-009-9311-y

Other articles of this Issue 1/2010

Journal of Clinical Immunology 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine